- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/38 - Nitrogen atoms
Patent holdings for IPC class C07D 215/38
Total number of patents in this class: 884
10-year publication summary
|
50
|
53
|
39
|
46
|
60
|
39
|
33
|
32
|
27
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 11023 |
40 |
| Abivax | 137 |
36 |
| Institut Curie | 615 |
36 |
| Universite de Montpellier | 1042 |
32 |
| Aldeyra Therapeutics, Inc. | 98 |
22 |
| Vertex Pharmaceuticals Incorporated | 1582 |
17 |
| Janssen Pharmaceutica N.V. | 3168 |
13 |
| Syngenta Participations AG | 1524 |
11 |
| Corteva Agriscience LLC | 2648 |
11 |
| F. Hoffmann-La Roche AG | 7837 |
8 |
| The Regents of the University of California | 20745 |
8 |
| Alcon, Inc. | 5861 |
8 |
| HMI Medical Innovations, LLC | 14 |
8 |
| Merck Sharp & Dohme LLC | 3734 |
8 |
| Takeda Pharmaceutical Company Limited | 2712 |
7 |
| Gilead Sciences, Inc. | 2222 |
7 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 318 |
7 |
| Bristol-myers Squibb Company | 4742 |
6 |
| Johnson Matthey Public Limited Company | 1768 |
6 |
| Boehringer Ingelheim International GmbH | 4493 |
5 |
| Other owners | 588 |